Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 4.66% is 64% below its 5-year average of 12.81%, near the low end of its 5-year range (0.00%–42.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.23% below its 12-month average of 6.00%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.66%.
DEBT TO ASSETS RATIO
4.66%
DEBT TO ASSETS RATIO AVG TTM
6.00%
DEBT TO ASSETS RATIO AVG 3Y
13.82%
DEBT TO ASSETS RATIO AVG 5Y
12.81%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-22.23%
CURRENT VS 3Y AVG
-66.24%
CURRENT VS 5Y AVG
-63.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.12%
median of 395 covered companies
CURRENT VS SECTOR MEDIAN
+3786.94%
vs the sector median at left
Cardio Diagnostics Holdings, Inc.
Market Cap
$6.10M
Debt to Assets Ratio
4.66%
TTM Avg
6.00%
3Y Avg
13.82%
5Y Avg
12.81%
Market Cap
$6.09M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.03M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.44M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.63M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.72M
Debt to Assets Ratio
0.54%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | $6.10M | 4.66% | 6.00% | 13.82% | 12.81% |
| Femasys Inc. (FEMY)vs › | $6.10M | 0.39% | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | 0.06% | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.34M | 0.28% | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.07% | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | 0.54% | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.74M | 0.00% | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 0.00% | N/A | N/A | N/A |
Debt/Assets
4.7%
Debt/Equity
0.05
Current Ratio
17.15
Interest Coverage
-438.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 4.66% |
| 2026-03-31 | 5.58% |
| 2025-12-31 | 8.96% |
| 2025-09-30 | 5.54% |
| 2025-06-30 | 5.26% |
| 2025-03-31 | 4.93% |
| 2024-12-31 | 9.14% |
| 2024-09-30 | 16.08% |
| 2024-06-30 | 21.78% |
| 2024-03-31 | 24.63% |
| 2023-12-31 | 28.26% |
| 2023-09-30 | 31.29% |
| 2023-06-30 | 13.54% |
| 2023-03-31 | 3.68% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 42.93% |
| 2021-06-30 | 42.86% |
